Agilent: Your preferred partner for precision medicine

Integrating Genomics Solutions with Dako Pathology

Known worldwide for our Dako pathology staining solutions, Agilent is excited to offer our leadership and innovation in genomics to the rapidly changing pathology laboratory. It is Agilent’s goal to enable the adoption and mastery of next generation sequencing (NGS) in the pathology laboratory workflow.

Complete Confidence

Working in the rapidly evolving fields of genomics, pathologists require complete confidence in a portfolio of workflow solutions for cancer applications in order to efficiently keep pace with innovation.

As the use of next-generation sequencing (NGS) for tumor profiling rapidly gains importance in pathology, adopting this technology requires expertise beyond traditional cellular and molecular testing. Agilent’s Genomics portfolio delivers support to harness the promise of NGS in pathology, from upstream solutions for sample quality control and target enrichment, to downstream data analysis and clinical interpretation.

In our eSeminars, we offer you guidance from our Field Application Scientists and Product Specialists to enable your implementation of standard operating procedures for NGS workflows—from sample DNA,  to raw reads, to final lab report—building your knowledge and confidence as you enter the new NGS frontier.

Register for our NGS eSeminars on-demand here

Take a deeper dive into our next generation pathology and NGS product offerings:

Dako molecular pathology solutions
Hybridization-based Next Generation Sequencing
Amplicon-based Next Generation Sequencing
Clinical Informatics

Company Information

Only Agilent's proven genomics solutions provide end-to-end insights, more accurate results, and the ability to more effectively enhance your laboratory's throughput and productivity.